Wang Jing, Tian Xiaoxiang, Yan Chenghui, Wu Hanlin, Bu Yuxin, Li Jia, Liu Dan, Han Yaling
Cardiovascular Research Institute and Department of Cardiology, General Hospital of Northern Theater Command, Shenyang, China.
JACC Basic Transl Sci. 2022 Nov 30;8(2):155-170. doi: 10.1016/j.jacbts.2022.07.012. eCollection 2023 Feb.
Phenotypic switching of vascular smooth muscle cells is a central process in abdominal aortic aneurysm (AAA) pathology. We found that knockdown TCF7L1 (transcription factor 7-like 1), a member of the TCF/LEF (T cell factor/lymphoid enhancer factor) family of transcription factors, inhibits vascular smooth muscle cell differentiation. This study hints at potential interventions to maintain a normal, differentiated smooth muscle cell state, thereby eliminating the pathogenesis of AAA. In addition, our study provides insights into the potential use of TCF7L1 as a biomarker for AAA.
血管平滑肌细胞的表型转换是腹主动脉瘤(AAA)病理过程中的核心环节。我们发现,敲低TCF7L1(转录因子7样蛋白1),即TCF/LEF(T细胞因子/淋巴增强因子)转录因子家族的一员,会抑制血管平滑肌细胞分化。这项研究提示了维持正常、分化的平滑肌细胞状态从而消除AAA发病机制的潜在干预措施。此外,我们的研究为TCF7L1作为AAA生物标志物的潜在用途提供了见解。